These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel and existing data for a future physiological toxicokinetic model of ethylene and its metabolite ethylene oxide in mouse, rat, and human. Filser JG; Artati A; Li Q; Pütz C; Semder B; Klein D; Kessler W Chem Biol Interact; 2015 Nov; 241():76-86. PubMed ID: 25868680 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide. Walker VE; Wu KY; Upton PB; Ranasinghe A; Scheller N; Cho MH; Vergnes JS; Skopek TR; Swenberg JA Carcinogenesis; 2000 Sep; 21(9):1661-9. PubMed ID: 10964097 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and disposition in toxicology. Example: carcinogenic risk estimate for ethylene. Bolt HM; Filser JG Arch Toxicol; 1987; 60(1-3):73-6. PubMed ID: 3619647 [TBL] [Abstract][Full Text] [Related]
7. Is ambient ethene a cancer risk factor? Törnqvist M Environ Health Perspect; 1994 Oct; 102 Suppl 4(Suppl 4):157-60. PubMed ID: 7821290 [TBL] [Abstract][Full Text] [Related]
8. Styrene, its metabolism and the evaluation of hazards in industry. Bardodĕj Z Scand J Work Environ Health; 1978; 4 Suppl 2():95-103. PubMed ID: 734423 [TBL] [Abstract][Full Text] [Related]
9. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Bolt HM; Foth H; Hengstler JG; Degen GH Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638 [TBL] [Abstract][Full Text] [Related]
10. Research needs to improve risk assessment of fiber toxicity. Greim HA Mutat Res; 2004 Sep; 553(1-2):11-22. PubMed ID: 15288529 [TBL] [Abstract][Full Text] [Related]
11. Relationship between dose in vivo of ethylene oxide and exposure to ethene studied in exposed workers. Granath F; Rohlén O; Göransson C; Hansson L; Magnusson AL; Törnqvist M Hum Exp Toxicol; 1996 Oct; 15(10):826-33. PubMed ID: 8906432 [TBL] [Abstract][Full Text] [Related]
12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
13. Olefinic hydrocarbons: a first risk estimate for ethene. Bolt HM; Filser JG Toxicol Pathol; 1984; 12(1):101-5. PubMed ID: 6494729 [TBL] [Abstract][Full Text] [Related]
14. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens. Lutz WK Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Hernández LG; van Steeg H; Luijten M; van Benthem J Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282 [TBL] [Abstract][Full Text] [Related]
16. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis. Bolt HM; Degen GH Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528 [TBL] [Abstract][Full Text] [Related]
17. DNA adducts and related biomarkers in populations exposed to environmental carcinogens. Perera F; Brenner D; Jeffrey A; Mayer J; Tang D; Warburton D; Young TI; Wazneh L; Latriano L; Motykiewicz G Environ Health Perspect; 1992 Nov; 98():133-7. PubMed ID: 1486841 [TBL] [Abstract][Full Text] [Related]
18. Relevance of experimental studies to human risk. Dietz FK; Ramsey JC; Watanabe PG Environ Health Perspect; 1983 Oct; 52():9-14. PubMed ID: 6653541 [TBL] [Abstract][Full Text] [Related]